Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing frailty in patients undergoing left atrial appendage closure

Official title: Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure The Frail-LAAC Study

Run by Institut universitaire de cardiologie et de pneumologie de Québec, University Laval · NCT05257954 · Data updated 2026-11-12

This study is trying to see how frailty affects the health and quality of life of patients getting a specific heart procedure called left atrial appendage closure.

More Frailty trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval
Academic / other
Locations1 site (Québec, Quebec)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedMarch 1, 2027
Study endsMarch 1, 2029
Registry record updatedMarch 24, 2026
Trial IDNCT05257954 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are undergoing transcatheter LAAC.

Probably not a fit

Patients who are unable to provide informed consent or have severe neuropsychiatric impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the prevalence and severity of frailty in patients who are undergoing transcatheter left atrial appendage closure (LAAC). It will investigate the relationship between frailty and both peri-procedural and long-term outcomes, as well as the impact on patients' quality of life. The study recognizes that while LAAC is a promising alternative to anticoagulation therapy, the high-risk nature of the patient population necessitates better selection criteria to improve outcomes. By understanding frailty in this context, the study seeks to enhance patient management and procedural success.

Why it matters

Potential benefit: If successful, this study could lead to improved patient selection and outcomes for those undergoing LAAC.

How similar studies have gone: Other studies have highlighted the importance of patient selection in LAAC procedures, indicating that this approach is relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Transcatheter LAAC with any approved device
* Age ≥18 years old

Exclusion Criteria:

* Unable to provide informed consent
* Severe neuropsychiatric impairment

Where it's running

  • Iucpq_ul
    Québec, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.